Fabio Rocha FormigaFabio Rocha Formiga graduated in pharmaceutical sciences, obtaining
his bachelor’s degree in 2004 from the Federal University of Rio Grande do
Norte, Brazil, where he also concluded a master’s course in health sciences.
In 2011, he obtained PhD in pharmaceutical technology from the University
of Navarra in Spain, with distinctions, as a MAEC-AECID scholar. In 2018,
he completed a research training in nanobiomaterials at the Rice University
(Houston, United States). Dr. Formiga has worked as a visiting professor at
the University of Coimbra, Portugal. He has experience in teaching/supervision
at the BSc, MSc, and PhD levels. In addition, he has acted as referee for
national and foreign funding agencies. He has participated as a member of university
committees, examination boards, and has organized scientific meetings,
including the 22nd International Symposium on Microencapsulation (Chair).
Dr. Formiga has also been strongly involved in collaborative programs for exchange
with European universities (from Portugal, Spain, and Denmark). He is
a cofounder and vice-president of the Brazilian Chapter of Controlled Release
Society (CRS, 2019–present) and guest associate editor of the Drug Delivery
and Translational Research (Springer) and Pharmaceutical Nanotechnology
(Bentham). He is a member of the Brazilian Association of Pharmaceutical
Sciences (ABCF) and the European Foundation for Clinical Nanomedicine
(CLINAM). Currently, Dr. Formiga is a research scientist and deputy head of
the Department of Immunology at the Aggeu Magalhães Institute, Oswaldo
Cruz Foundation (FIOCRUZ), Brazil. He also holds a tenured adjunct professor
position at University of Pernambuco (UPE). Dr. Formiga was acknowledged
with the Research Award from Spanish Society of Pharmaceutics and
Pharmaceutical Technology (SEFIG) in 2013 and the Benjamin Gilbert Award
from FIOCRUZ in 2017. His research has focused on pharmaceutics, drug delivery,
nanotechnology, and biomaterials toward neglected tropical diseases and
regenerative medicine. Read More Read Less